Innospec (NASDAQ: IOSP) is one of 52 public companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its peers? We will compare Innospec to related companies based on the strength of its risk, profitability, earnings, institutional ownership, dividends, analyst recommendations and valuation.

Earnings & Valuation

This table compares Innospec and its peers gross revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Innospec $1.06 billion $150.30 million 19.76
Innospec Competitors $1.95 billion $301.94 million 12.61

Innospec’s peers have higher revenue and earnings than Innospec. Innospec is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Innospec has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Innospec’s peers have a beta of 1.60, indicating that their average share price is 60% more volatile than the S&P 500.


Innospec pays an annual dividend of $0.76 per share and has a dividend yield of 1.2%. Innospec pays out 24.3% of its earnings in the form of a dividend. As a group, “Specialty Chemicals” companies pay a dividend yield of 1.4% and pay out 26.7% of their earnings in the form of a dividend.


This table compares Innospec and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innospec 7.22% 14.77% 8.39%
Innospec Competitors -2.53% 9.11% 3.88%

Analyst Recommendations

This is a breakdown of current recommendations for Innospec and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innospec 0 0 1 0 3.00
Innospec Competitors 166 1029 1282 24 2.47

Innospec currently has a consensus target price of $65.00, suggesting a potential upside of 5.09%. As a group, “Specialty Chemicals” companies have a potential downside of 4.49%. Given Innospec’s stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than its peers.

Insider & Institutional Ownership

89.1% of Innospec shares are owned by institutional investors. Comparatively, 69.1% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 2.0% of Innospec shares are owned by company insiders. Comparatively, 7.1% of shares of all “Specialty Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.


Innospec beats its peers on 9 of the 15 factors compared.

Innospec Company Profile

Innospec Inc. is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives. Its Fuel Specialties develops, manufactures, blends, markets and supplies various specialty chemical products that are used as additives for a range of fuels. Its Performance Chemicals provides technology-based solutions. Its Oilfield Services business supplies drilling, completion and production chemicals. Its Octane Additives business manufactures a fuel additive for use in automotive gasoline and provides services in respect of environmental remediation. Its customers include oil and gas exploration and production companies, fuel users, and oil refiners among others.

Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with's FREE daily email newsletter.